| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 42.711 | 58.953 | 58.232 | 67.929 | 82.359 | 98.635 |
| Total Income - EUR | - | - | - | 8.508 | 42.711 | 58.989 | 58.236 | 67.932 | 82.361 | 98.644 |
| Total Expenses - EUR | - | - | - | 8.995 | 21.451 | 35.324 | 29.053 | 31.863 | 37.354 | 58.761 |
| Gross Profit/Loss - EUR | - | - | - | -487 | 21.260 | 23.665 | 29.183 | 36.069 | 45.007 | 39.882 |
| Net Profit/Loss - EUR | - | - | - | -487 | 20.833 | 23.160 | 28.601 | 35.390 | 44.200 | 36.923 |
| Employees | - | - | - | 0 | 2 | 3 | 3 | 3 | 4 | 4 |
Check the financial reports for the company - Dana Medfam S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 1.093 | 721 | 2.050 |
| Current Assets | - | - | - | 43 | 22.060 | 46.871 | 30.341 | 37.579 | 47.609 | 57.278 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 7.691 | 24.213 | 22.652 | 29.099 | 33.713 | 33.805 |
| Cash | - | - | - | 43 | 14.369 | 22.658 | 7.689 | 8.480 | 13.896 | 23.473 |
| Shareholders Funds | - | - | - | -444 | 20.398 | 43.171 | 28.649 | 35.439 | 44.249 | 36.971 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 487 | 1.662 | 3.700 | 1.692 | 3.234 | 4.082 | 22.357 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dana Medfam S.r.l.